LEDS [SemiLEDs] 8-K: (Original Filing)

[CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SEMILEDS CORPORATION 1. 2. 3. 4. Executed Trung Tri Doan Chief Executive Officer EX-3.1 2 a16-6910_4ex3d1.htm EX-3.1] [SemiLEDs Announces Reverse Stock Split Hsinchu, Taiwan (April 1 5 , 201 6 ) — The Trading of the Company’s common stock on the NASDAQ Capital Market will continue, on a split-adjusted basis, with the opening of the markets on The Company has retained its transfer agent, American Stock Transfer & Trust Company, LLC (“AST”), to act as its exchange] []

By | 2016-04-16T04:51:50+00:00 April 15th, 2016|Categories: Chinese Stocks, LEDS, SEC Original|Tags: , , , , , |0 Comments
Read More

LEDS [SemiLEDs] 8-K: CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE

[CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SEMILEDS CORPORATION 1. 2. 3. 4. Executed Trung Tri Doan Chief Executive Officer EX-3.1 2 a16-6910_4ex3d1.htm EX-3.1] [SemiLEDs Announces Reverse Stock Split Hsinchu, Taiwan (April 1 5 , 201 6 ) — The Trading of the Company’s common stock on the NASDAQ Capital Market will continue, on a split-adjusted basis, with the opening of the markets on The Company has retained its transfer agent, American Stock Transfer & Trust Company, LLC (“AST”), to act as its exchange] []

By | 2016-04-16T04:53:58+00:00 April 15th, 2016|Categories: Chinese Stocks, LEDS, Webplus ver|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals] 10-K: (Original Filing)

[FORM 10-K (Mark One) x December 31, 2015 For the fiscal year ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 86-29-33686638 (Former name, former] [Biostar Pharmaceuticals, Inc. List of subsidiaries As of December 31, 2015 Name Place of incorporation Shaanxi Biostar Biotech Ltd People’s Republic of China Shaanxi Aoxing Pharmaceutical Co. Ltd. People’s Republic of China Shaanxi Weinan Haren Pharmaceuticals, Ltd. People’s Republic of China EX-21 2 ex21.htm EX-21] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Mazars CPA Limited Certified Public Accountants Hong Kong April 14, 2016 EX-23.1 3 ex23-1.htm EX-23.1] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Mazars CPA Limited Certified Public Accountants Hong Kong April 14, 2016 EX-23.2 4 ex23-2.htm EX-23.2] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated July 17, 2014 of Biostar Pharmaceuticals, Inc. of our report dated April 14, 2016 relating to the consolidated financial statements, which appears in the Annual Report on Form] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: April 14, 2016 Ronghua Wang Chief Executive Officer EX-32.1 8 ex32-1.htm EX-32.1] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: April 14, 2016 Qinghua Liu Interim Chief Financial Officer EX-32.2 9 ex32-2.htm EX-32.2]

By | 2016-04-15T02:22:59+00:00 April 14th, 2016|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals] 10-K: FORM 10-K (Mark One) x December 31, 2015

[FORM 10-K (Mark One) x December 31, 2015 For the fiscal year ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 86-29-33686638 (Former name, former] [Biostar Pharmaceuticals, Inc. List of subsidiaries As of December 31, 2015 Name Place of incorporation Shaanxi Biostar Biotech Ltd People’s Republic of China Shaanxi Aoxing Pharmaceutical Co. Ltd. People’s Republic of China Shaanxi Weinan Haren Pharmaceuticals, Ltd. People’s Republic of China EX-21 2 ex21.htm EX-21] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Mazars CPA Limited Certified Public Accountants Hong Kong April 14, 2016 EX-23.1 3 ex23-1.htm EX-23.1] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Mazars CPA Limited Certified Public Accountants Hong Kong April 14, 2016 EX-23.2 4 ex23-2.htm EX-23.2] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated July 17, 2014 of Biostar Pharmaceuticals, Inc. of our report dated April 14, 2016 relating to the consolidated financial statements, which appears in the Annual Report on Form] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: April 14, 2016 Ronghua Wang Chief Executive Officer EX-32.1 8 ex32-1.htm EX-32.1] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: April 14, 2016 Qinghua Liu Interim Chief Financial Officer EX-32.2 9 ex32-2.htm EX-32.2]

By | 2016-04-15T02:23:48+00:00 April 14th, 2016|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

CNET [ChinaNet Online] 8-K: (Original Filing)

[ChinaNet Online Holdings Reports Fiscal Year 2015 Financial Results 2015 total revenues decreased by 15% YOY to $32.3 million 2015 Gross margin increased to 23.6%, a 42.2% increase YOY 2015 internet advertisement revenues increased to $19.6 million, a 11% increase YOY Full year net loss attributable to ChinaNet decreased by $4.6 million YOY to $9.1 million BEIJING, April 15, 2016] [Form 8-K CURRENT REPORT Date of Report (Date of earliest event Reported): April 14, 2016 ChinaNet Online Holdings, Inc. Nevada 001-34647 20-4672080 (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification Number) No. 3 Min Zhuang Road, Building 6, +86-10-6900-5520 [ ] [ ] [ ] [ ] Item 2.02. Results of Operations and Financial Condition. No. Description ChinaNet Online]

By | 2016-04-15T02:25:12+00:00 April 14th, 2016|Categories: Chinese Stocks, CNET, SEC Original|Tags: , , , , , |0 Comments
Read More

CNET [ChinaNet Online] 8-K: ChinaNet Online Holdings Reports Fiscal Year 2015 Financial

[ChinaNet Online Holdings Reports Fiscal Year 2015 Financial Results 2015 total revenues decreased by 15% YOY to $32.3 million 2015 Gross margin increased to 23.6%, a 42.2% increase YOY 2015 internet advertisement revenues increased to $19.6 million, a 11% increase YOY Full year net loss attributable to ChinaNet decreased by $4.6 million YOY to $9.1 million BEIJING, April 15, 2016] [Form 8-K CURRENT REPORT Date of Report (Date of earliest event Reported): April 14, 2016 ChinaNet Online Holdings, Inc. Nevada 001-34647 20-4672080 (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification Number) No. 3 Min Zhuang Road, Building 6, +86-10-6900-5520 [ ] [ ] [ ] [ ] Item 2.02. Results of Operations and Financial Condition. No. Description ChinaNet Online]

By | 2016-04-15T02:26:02+00:00 April 14th, 2016|Categories: Chinese Stocks, CNET, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar